{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:41:09Z","timestamp":1791420069927,"version":"4.3.3"},"reference-count":59,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0611","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T14:09:02Z","timestamp":1536242942000},"source":"Crossref","is-referenced-by-count":72,"title":["The Diagnosis and Treatment of Anxiety Disorders"],"prefix":"10.3238","author":[{"given":"Andreas","family":"Str\u00f6hle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Gensichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"10.3238\/arztebl.2018.0611_ref1","doi-asserted-by":"crossref","unstructured":"Wittchen HU, Jacobi F, Rehm J, et al.: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 9: 655\u201379","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"10.3238\/arztebl.2018.0611_ref2","unstructured":"WHO: Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO (http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/254610\/WHO-MSD-MER-2017.2-eng.pdf;jsessionid=829EAD6A4E0473EBDE28F4FD23B8D556?sequence=1) (last accessed on 22 August 2018)."},{"key":"10.3238\/arztebl.2018.0611_ref3","unstructured":"Dilling H: Internationale Klassifikation Psychischer St\u00f6rungen: ICD-10 Kapitel V (F); Klinisch-diagnostische Leitlinien. 8th revised edition ICD-10-GM 2011. Bern: Huber 2011."},{"key":"10.3238\/arztebl.2018.0611_ref4","unstructured":"WHO: ICD-11. https:\/\/icd.who.int\/dev11\/l-m\/en. (last accessed on 22 August 2018)."},{"key":"10.3238\/arztebl.2018.0611_ref5","doi-asserted-by":"crossref","unstructured":"Silove D, Alonso J, Bromet E, et al.: Pediatric-onset and adult-onset separation anxiety disorder across countries in the world mental health survey. Am J Psychiatry 2015; 172: 647\u201356","DOI":"10.1176\/appi.ajp.2015.14091185"},{"key":"10.3238\/arztebl.2018.0611_ref6","doi-asserted-by":"crossref","unstructured":"Baldwin DS, Gordon R, Abelli M, Pini S: The separation of adult separation anxiety disorder. CNS Spectrums 2016; 21: 289\u201394","DOI":"10.1017\/S1092852916000080"},{"key":"10.3238\/arztebl.2018.0611_ref7","doi-asserted-by":"crossref","unstructured":"Rogoll J, Petzold M, Str\u00f6hle A: Selektiver Mutismus. Nervenarzt 2018; 89: 591\u2013602","DOI":"10.1007\/s00115-018-0504-6"},{"key":"10.3238\/arztebl.2018.0611_ref8","doi-asserted-by":"crossref","unstructured":"Kossowsky J, Pfaltz MC, Schneider S, Taeymans J, Locher C, Gaab J: The separation anxiety hypothesis of panic disorder revisited: a meta-analysis. Am J Psychiatry 2013; 170: 768\u201381","DOI":"10.1176\/appi.ajp.2012.12070893"},{"key":"10.3238\/arztebl.2018.0611_ref9","doi-asserted-by":"crossref","unstructured":"Grant BF, Goldstein RB, Saha TD, et al.: Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry 2015; 72: 757\u201366","DOI":"10.1001\/jamapsychiatry.2015.0584"},{"key":"10.3238\/arztebl.2018.0611_ref10","doi-asserted-by":"crossref","unstructured":"Meier SM, Petersen L, Mattheisen M, Mors O, Mortensen PB, Laursen TM: Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark. Lancet Psychiatry 2015; 2: 515\u201323","DOI":"10.1016\/S2215-0366(15)00092-9"},{"key":"10.3238\/arztebl.2018.0611_ref11","doi-asserted-by":"crossref","unstructured":"Tawakol A, Ishai A, Takx RA, et al.: Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet 2017; 389: 834\u201345","DOI":"10.1016\/S0140-6736(16)31714-7"},{"key":"10.3238\/arztebl.2018.0611_ref12","doi-asserted-by":"crossref","unstructured":"Batty GD, Russ TC, Stamatakis E, Kivim\u00e4ki M: Psychological distress in relation to site specific cancer mortality: pooling of unpublished data from 16 prospective cohort studies. BMJ 2017; 356: j108.","DOI":"10.1136\/bmj.j108"},{"key":"10.3238\/arztebl.2018.0611_ref13","doi-asserted-by":"crossref","unstructured":"Gottschalk MG, Domschke K: Novel developments in genetic and epigenetic mechanisms of anxiety. Curr Opin Psychiatry 2016; 29: 32\u20138","DOI":"10.1097\/YCO.0000000000000219"},{"key":"10.3238\/arztebl.2018.0611_ref14","doi-asserted-by":"crossref","unstructured":"Klauke B, Deckert J, Reif A, Pauli P, Domschke K: Life events in panic disorder\u2014an update on \u201ecandidate stressors\u201c. Depress Anxiety 2010; 27: 716\u201330","DOI":"10.1002\/da.20667"},{"key":"10.3238\/arztebl.2018.0611_ref15","doi-asserted-by":"crossref","unstructured":"Schiele MA, Domschke K: Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav 2018; 17: e12423","DOI":"10.1111\/gbb.12423"},{"key":"10.3238\/arztebl.2018.0611_ref16","doi-asserted-by":"crossref","unstructured":"Ziegler C, Richter J, Mahr M, et al.: MAOA gene hypomethylation in panic disorder\u2014reversibility of an epigenetic risk pattern by psychotherapy. Transl Psychiatry 2016; 6: e773","DOI":"10.1038\/tp.2016.41"},{"key":"10.3238\/arztebl.2018.0611_ref17","doi-asserted-by":"crossref","unstructured":"Bandelow B, Baldwin D, Abelli M, et al.: Biological markers for anxiety disorders, OCD and PTSD\u2014a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry 2016; 17: 321\u201365","DOI":"10.1080\/15622975.2016.1181783"},{"key":"10.3238\/arztebl.2018.0611_ref18","doi-asserted-by":"crossref","unstructured":"Bandelow B, Baldwin D, Abelli M, et al.: Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry 2017; 18: 162\u2013214","DOI":"10.1080\/15622975.2016.1190867"},{"key":"10.3238\/arztebl.2018.0611_ref19","doi-asserted-by":"crossref","unstructured":"Lebow MA, Chen A: Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry 2016; 4: 450\u201363","DOI":"10.1038\/mp.2016.1"},{"key":"10.3238\/arztebl.2018.0611_ref20","unstructured":"Bandelow B, Wiltink J, Alpers GW, et al.: Deutsche S3-Leitlinie Behandlung von Angstst\u00f6rungen. (last accessed on 13 August 2018)."},{"key":"10.3238\/arztebl.2018.0611_ref21","doi-asserted-by":"crossref","unstructured":"Leichsenring F, Salzer S, Beutel ME, et al.: Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial. Am J PSychiatry 2013; 170: 759\u201367","DOI":"10.1176\/appi.ajp.2013.12081125"},{"key":"10.3238\/arztebl.2018.0611_ref22","doi-asserted-by":"crossref","unstructured":"Gloster AT, Wittchen HU, Einsle F, et al.: Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J Consult Clin Psychol 2011; 79: 406\u201320","DOI":"10.1037\/a0023584"},{"key":"10.3238\/arztebl.2018.0611_ref23","doi-asserted-by":"crossref","unstructured":"Diemer J, M\u00fchlberger A, Pauli P, Zwanzger P: Virtual reality exposure in anxiety disorders: impact on psychophysiological reactivity. World J Biol Psychiatry 2014; 15: 427\u201342","DOI":"10.3109\/15622975.2014.892632"},{"key":"10.3238\/arztebl.2018.0611_ref24","doi-asserted-by":"crossref","unstructured":"Bandelow B, Reitt M, R\u00f6ver C, Michaelis S, G\u00f6rlich Y, Wedekind D: Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 2015; 30: 183\u201392","DOI":"10.1097\/YIC.0000000000000078"},{"key":"10.3238\/arztebl.2018.0611_ref25","doi-asserted-by":"crossref","unstructured":"Bandelow B, Sagebiel A, Belz M, G\u00f6rlich Y, Michaelis S, Wedekind D: Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry 2018; 212: 333\u20138","DOI":"10.1192\/bjp.2018.49"},{"key":"10.3238\/arztebl.2018.0611_ref26","doi-asserted-by":"crossref","unstructured":"Bonnet U, Scherbaum N: How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol 2017; 27: 1185\u2013215","DOI":"10.1016\/j.euroneuro.2017.08.430"},{"key":"10.3238\/arztebl.2018.0611_ref27","doi-asserted-by":"crossref","unstructured":"Perna G, Alciati A, Riva A, Micieli W, Caldirola D: Long-term pharmacological treatments of anxiety disorders: an updated systematic review. Curr Psychiatry Rep 2016; 18: 23","DOI":"10.1007\/s11920-016-0668-3"},{"key":"10.3238\/arztebl.2018.0611_ref28","doi-asserted-by":"crossref","unstructured":"Soyka M: Treatment of benzodiazepine dependence. N Engl J Med 2017; 376: 1147\u201357","DOI":"10.1056\/NEJMra1611832"},{"key":"10.3238\/arztebl.2018.0611_ref29","doi-asserted-by":"crossref","unstructured":"Normann N, Emmerik AAP, Morina N: The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review. Depression Anxiety 2014; 31: 402\u201311","DOI":"10.1002\/da.22273"},{"key":"10.3238\/arztebl.2018.0611_ref30","doi-asserted-by":"crossref","unstructured":"Gloster AT, Sonntag R, Hoyer J, et al.: Treating treatment-resistant patients with panic disorder and agoraphobia using psychotherapy: a randomized controlled switching trial. PPS 2015; 84: 100\u20139","DOI":"10.1159\/000370162"},{"key":"10.3238\/arztebl.2018.0611_ref31","doi-asserted-by":"crossref","unstructured":"Rodrigues MF, Nardi AE, Levitan M: Mindfulness in mood and anxiety disorders: a review of the literature. Trends Psychiatr Psychoth 2017; 39: 207\u201315","DOI":"10.1590\/2237-6089-2016-0051"},{"key":"10.3238\/arztebl.2018.0611_ref32","doi-asserted-by":"crossref","unstructured":"Zwanzger P, Fallgatter AJ, Zavorotnyy M, Padberg F: Anxiolytic effects of transcranial magnetic stimulation\u2014an alternative treatment option in anxiety disorders? J Neural Transm 2009; 116: 767\u201375","DOI":"10.1007\/s00702-008-0162-0"},{"key":"10.3238\/arztebl.2018.0611_ref33","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A: Sports psychiatry: mental health and mental disorders in athletes and exercise treatment of mental disorders. Eur Arch Psychiatry Clin Neurosci 2018 [Epub ahead of print]","DOI":"10.1007\/s00406-018-0891-5"},{"key":"10.3238\/arztebl.2018.0611_ref34","doi-asserted-by":"crossref","unstructured":"Gaudlitz K, Plag J, Dimeo F, Str\u00f6hle A: Aerobic exercise training facilitates the effectiveness of cognitive behavioral therapy in panic disorder. Depression Anxiety 2015; 32: 221\u20138","DOI":"10.1002\/da.22337"},{"key":"10.3238\/arztebl.2018.0611_ref35","doi-asserted-by":"crossref","unstructured":"Bischoff S, Wieder G, Einsle F, et al.: Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia. J Psychiatr Res 2018; 101: 34\u201341","DOI":"10.1016\/j.jpsychires.2018.03.001"},{"key":"10.3238\/arztebl.2018.0611_ref36","doi-asserted-by":"crossref","unstructured":"Archer J, Bower P, Gilbody S, et al.: Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012; 10: CD006525","DOI":"10.1002\/14651858.CD006525.pub2"},{"key":"10.3238\/arztebl.2018.0611_ref37","doi-asserted-by":"crossref","unstructured":"Hiller TS, Freytag A, Breitbart J, et al.: Die Jena Angst-Monitoring-Liste (JAMoL) \u2013 ein Instrument zur evidenzbasierten Behandlung von Panikst\u00f6rung mit oder ohne Agoraphobie in der Hausarztpraxis. Z Ev Fortbil Qualit\u00e4t Gesundheitsw 2018; 131\u2013132: 28\u201337","DOI":"10.1016\/j.zefq.2018.02.003"},{"key":"10.3238\/arztebl.2018.0611_ref38","doi-asserted-by":"crossref","unstructured":"Schumacher S, Gaudlitz K, Plag J, et al.: Who is stressed? A pilot study of salivary cortisol and alpha-amylase concentrations in agoraphobic patients and their novice therapists undergoing in vivo exposure. Psychoneuroendocrinology 2014; 49: 280\u20139","DOI":"10.1016\/j.psyneuen.2014.07.016"},{"key":"10.3238\/arztebl.2018.0611_ref39","doi-asserted-by":"crossref","unstructured":"Schumacher S, Miller R, Fehm L, Kirschbaum C, Fydrich T, Str\u00f6hle A: Therapists\u2018 and patients\u2018 stress responses during graduated versus flooding in vivo exposure in the treatment of specific phobia: a preliminary observational study. Psychiatry Res 2015; 230: 668\u201375","DOI":"10.1016\/j.psychres.2015.10.020"},{"key":"10.3238\/arztebl.2018.0611_ref40","unstructured":"Domschke K, Deckert J: Pr\u00e4vention von Angstst\u00f6rungen. Handbuch Pr\u00e4vention psychischer St\u00f6rungen. Stuttgart: Schattauer 2017."},{"key":"10.3238\/arztebl.2018.0611_ref41","doi-asserted-by":"crossref","unstructured":"Eisner MD, Blanc PD, Yelin EH, et al.: Influence of anxiety on health outcomes in COPD. Thorax 2010; 65: 229\u201334","DOI":"10.1136\/thx.2009.126201"},{"key":"10.3238\/arztebl.2018.0611_ref42","doi-asserted-by":"crossref","unstructured":"Tully PJ, Cosh SM, Baumeister H: The anxious heart in whose mind? A systematic review and meta-regression of factors associated with anxiety disorder diagnosis, treatment and morbidity risk in coronary heart disease. J Psychosom Res 2014; 77: 439\u201348","DOI":"10.1016\/j.jpsychores.2014.10.001"},{"key":"10.3238\/arztebl.2018.0611_ref43","doi-asserted-by":"crossref","unstructured":"Burton C, Campbell P, Jordan K, Strauss V, Mallen C: The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care. Fam Pract 2013; 30: 25\u201330","DOI":"10.1093\/fampra\/cms044"},{"key":"10.3238\/arztebl.2018.0611_ref44","doi-asserted-by":"crossref","unstructured":"Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002; 53: 1053\u201360","DOI":"10.1016\/S0022-3999(02)00417-8"},{"key":"10.3238\/arztebl.2018.0611_ref45","doi-asserted-by":"crossref","unstructured":"Beesdo K, Pine DS, Lieb R, Wittchen HU: Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. Arch Gen Psychiatry 2010; 67: 47\u201357","DOI":"10.1001\/archgenpsychiatry.2009.177"},{"key":"10.3238\/arztebl.2018.0611_ref46","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 5th edition. DSM-5 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.3238\/arztebl.2018.0611_ref47","doi-asserted-by":"crossref","unstructured":"Shear KM, Bjelland I, Beesdo K, Gloster AT, Wittchen HU: Supplementary dimensional assessment in anxiety disorders. Int J Methods Psychiatr Res 2007; 16(Suppl 1): 52\u201364","DOI":"10.1002\/mpr.215"},{"key":"10.3238\/arztebl.2018.0611_ref48","doi-asserted-by":"crossref","unstructured":"Seligman ME: Phobias and preparedness\u2014republished article. Behav Ther 2016; 47: 577\u201384","DOI":"10.1016\/j.beth.2016.08.006"},{"key":"10.3238\/arztebl.2018.0611_ref49","doi-asserted-by":"crossref","unstructured":"Naragon-Gainey K, Watson D: What lies beyond neuroticism? An examination of the unique contributions of social-cognitive vulnerabilities to internalizing disorders. Assessment 2018; 25: 143\u201358","DOI":"10.1177\/1073191116659741"},{"key":"10.3238\/arztebl.2018.0611_ref50","doi-asserted-by":"crossref","unstructured":"Maneeton N, Maneeton B, Woottiluk P, et al.: Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2016; 10: 259\u201376","DOI":"10.2147\/DDDT.S89485"},{"key":"10.3238\/arztebl.2018.0611_ref51","doi-asserted-by":"crossref","unstructured":"Buoli M, Grassi S, Serati M, Altamura AC: Agomelatine for the treatment of generalized anxiety disorder. Expert Opin Pharmacother 2017; 18: 1373\u20139","DOI":"10.1080\/14656566.2017.1359257"},{"key":"10.3238\/arztebl.2018.0611_ref52","unstructured":"Kasper S, M\u00fcller WE, Volz HP, M\u00f6ller HJ, Koch E, Dienel A: Silexan in anxiety disorders: clinical data and pharmacological background. World J Biol Psychiatry 2017; 0: 1\u20139."},{"key":"10.3238\/arztebl.2018.0611_ref53","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A, Feller C, Onken M, Godemann F, Heinz A, Dimeo F: The acute antipanic activity of aerobic exercise. Am J Psychiatry 2005; 162: 2376\u20138","DOI":"10.1176\/appi.ajp.162.12.2376"},{"key":"10.3238\/arztebl.2018.0611_ref54","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A, Graetz B, Scheel M, et al.: The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects. J Psychiatr Res 2009; 43: 1013\u20137","DOI":"10.1016\/j.jpsychires.2009.02.004"},{"key":"10.3238\/arztebl.2018.0611_ref55","doi-asserted-by":"crossref","unstructured":"Lindenberger BL, Plag J, Schumacher S, et al.: Clinical and neurobiological effects of aerobic exercise in dental phobia: a randomized controlled trial. Depress Anxiety 2017; 34: 1040\u20138","DOI":"10.1002\/da.22659"},{"key":"10.3238\/arztebl.2018.0611_ref56","doi-asserted-by":"crossref","unstructured":"Rapee RM, Kennedy SJ, Ingram M, Edwards SL, Sweeney L: Altering the trajectory of anxiety in at-risk young children. Am J Psychiatry 2010; 167: 1518\u201325","DOI":"10.1176\/appi.ajp.2010.09111619"},{"key":"10.3238\/arztebl.2018.0611_ref57","doi-asserted-by":"crossref","unstructured":"Rapee RM: The preventative effects of a brief, early intervention for preschool-aged children at risk for internalising: follow-up into middle adolescence. J Child Psychol Psychiatry 2013; 54: 780\u20138","DOI":"10.1111\/jcpp.12048"},{"key":"10.3238\/arztebl.2018.0611_ref58","doi-asserted-by":"crossref","unstructured":"Fisak BJ, Richard D, Mann A: The prevention of child and adolescent anxiety: a meta-analytic review. Prev Sci 2011; 12, 255\u201368","DOI":"10.1007\/s11121-011-0210-0"},{"key":"10.3238\/arztebl.2018.0611_ref59","doi-asserted-by":"crossref","unstructured":"Moreno-Peral P, Conejo-Cer\u00f3n S, Rubio-Valera M, et al.: Effectiveness of psychological and\/or educational interventions in the prevention of anxiety: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry 2017; 74, 1021\u20139","DOI":"10.1001\/jamapsychiatry.2017.2509"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:59:28Z","timestamp":1638799168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":59,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0611","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]}}}